The estimated Net Worth of David Cecil Vanston is at least 319 千$ dollars as of 19 September 2017. Mr. Vanston owns over 2,750 units of VolitionRX Ltd stock worth over 1,922$ and over the last 8 years he sold VNRX stock worth over 0$. In addition, he makes 316,792$ as Chief Financial Officer、 Treasurer at VolitionRX Ltd.
David has made over 1 trades of the VolitionRX Ltd stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 2,750 units of VNRX stock worth 7,810$ on 19 September 2017.
The largest trade he's ever made was buying 2,750 units of VolitionRX Ltd stock on 19 September 2017 worth over 7,810$. On average, David trades about 393 units every 0 days since 2017. As of 19 September 2017 he still owns at least 2,750 units of VolitionRX Ltd stock.
You can see the complete history of Mr. Vanston stock trades at the bottom of the page.
David Vanston has been appointed as Chief Financial Officer, Treasurer of the Company. Mr. Vanston has over twenty years of financial management experience with a strong background as an international finance executive and a senior controller, including extensive experience in Sarbanes-Oxley compliance and implementation of successful change programs. Mr. Vanston was previously employed at Octo Telematics from 2016 to 2017, a high-growth technology company based in Boston, where he was the Senior Controller for the U.S. business. Prior to joining Octo Telematics, he held the position of Vice President of Excorp Medical, Inc., an early-stage company, from 2015 to 2016, and prior to that served as European Chief Financial Officer for Monster Worldwide, Inc. and Chief Financial Officer for GrowHow Ltd. Mr. Vanston managed and oversaw accounting, finance, tax, treasury, financial planning and analysis of GrowHow Ltd.’s business. Mr. Vanston is a certified chartered accountant and holds an MBA from Warwick Business School. The board of directors believes that Mr. Vanston’s financial and accounting knowledge is a valuable asset to the Company.
As the Chief Financial Officer、 Treasurer of VolitionRX Ltd, the total compensation of David Vanston at VolitionRX Ltd is 316,792$. There are 4 executives at VolitionRX Ltd getting paid more, with Cameron Reynolds having the highest compensation of 517,691$.
David Vanston is 52, he's been the Chief Financial Officer、 Treasurer of VolitionRX Ltd since 2017. There are 9 older and 12 younger executives at VolitionRX Ltd. The oldest executive at VolitionRX Ltd is Dr. Martin Charles Faulkes Ph.D., 77, who is the Exec. Chairman.
David's mailing address filed with the SEC is 13215 BEE CAVE PARKWAY, SUITE 125 GALLERIA OAKS B, AUSTIN, TX, 78738.
Over the last 12 years, insiders at VolitionRX Ltd have traded over 775,239$ worth of VolitionRX Ltd stock and bought 1,908,474 units worth 44,487,770,972$ . The most active insiders traders include Guy Archibald Innes、Cameron John Reynolds、Martin Charles Faulkes. On average, VolitionRX Ltd executives and independent directors trade stock every 43 days with the average trade being worth of 27,899$. The most recent stock trade was executed by Guy Archibald Innes on 20 August 2024, trading 150,000 units of VNRX stock currently worth 100,500$.
volitionrx is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. volitionrx’s development activities are currently centered in belgium with a focus on bringing its revolutionary diagnostic products to market first in europe, then the u.s. and worldwide. you can find more information about volitionrx at our website at www.volitionrx.com, on twitter at www.twitter.com/volitionrx, linkedin at http://www.linkedin.com/company/volitionrx or facebook at www.facebook.com/volitionrx.
VolitionRX Ltd executives and other stock owners filed with the SEC include: